These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 25214578)

  • 1. Response to letter regarding article, "renal denervation for the treatment of cardiovascular high risk-hypertension or beyond?".
    Linz D; Ukena C; Esler M; Böhm M; Mahfoud F
    Circ Res; 2014 Sep; 115(7):e19-20. PubMed ID: 25214578
    [No Abstract]   [Full Text] [Related]  

  • 2. Letter by Wang regarding article, "renal denervation for the treatment of cardiovascular high risk-hypertension or beyond?".
    Wang Y
    Circ Res; 2014 Sep; 115(7):e18. PubMed ID: 25214577
    [No Abstract]   [Full Text] [Related]  

  • 3. Renal denervation for the treatment of cardiovascular high risk-hypertension or beyond?
    Böhm M; Linz D; Ukena C; Esler M; Mahfoud F
    Circ Res; 2014 Jul; 115(3):400-9. PubMed ID: 25035133
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Renal sympathetic denervation using an electroanatomic mapping system.
    Miller MA; Gangireddy SR; Dukkipati SR; Koruth JS; d'Avila A; Reddy VY
    J Am Coll Cardiol; 2014 Apr; 63(16):1697. PubMed ID: 24613336
    [No Abstract]   [Full Text] [Related]  

  • 5. Renal sympathetic denervation for resistant hypertension: where do we stand after more than a decade.
    Fontes MAP; Marzano LAS; Silva CC; Silva ACS
    J Bras Nefrol; 2020 Mar; 42(1):67-76. PubMed ID: 31939995
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Transcatheter renal artery sympathetic denervation for resistant hypertension: an old paradigm revisited.
    Tam GM; Yan BP; Shetty SV; Lam YY
    Int J Cardiol; 2013 Apr; 164(3):277-81. PubMed ID: 22336259
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Renal denervation as a therapeutic approach for hypertension: novel implications for an old concept.
    Schlaich MP; Sobotka PA; Krum H; Whitbourn R; Walton A; Esler MD
    Hypertension; 2009 Dec; 54(6):1195-201. PubMed ID: 19822798
    [No Abstract]   [Full Text] [Related]  

  • 8. Renal denervation: a novel non-pharmacological approach in heart failure.
    Böhm M; Ewen S; Linz D; Reil JC; Schirmer S; Ukena C; Mahfoud F
    J Cardiovasc Transl Res; 2014 Apr; 7(3):330-7. PubMed ID: 24578253
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Renal sympathetic denervation in refractory hypertension].
    Sans Atxer L; Oliveras A
    Med Clin (Barc); 2013 Mar; 140(6):263-5. PubMed ID: 23276614
    [No Abstract]   [Full Text] [Related]  

  • 10. Feasibility of catheter-based renal nerve ablation and effects on sympathetic nerve activity and blood pressure in patients with end-stage renal disease.
    Schlaich MP; Bart B; Hering D; Walton A; Marusic P; Mahfoud F; Böhm M; Lambert EA; Krum H; Sobotka PA; Schmieder RE; Ika-Sari C; Eikelis N; Straznicky N; Lambert GW; Esler MD
    Int J Cardiol; 2013 Oct; 168(3):2214-20. PubMed ID: 23453868
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Letter by Anyfanti et al regarding article, "Effect of renal sympathetic denervation on glucose metabolism in patients with resistant hypertension: a pilot study".
    Anyfanti P; Gkaliagkousi E; Douma S
    Circulation; 2011 Nov; 124(20):e536; author reply e537. PubMed ID: 22083154
    [No Abstract]   [Full Text] [Related]  

  • 12. The sympathetic nervous system alterations in human hypertension.
    Grassi G; Mark A; Esler M
    Circ Res; 2015 Mar; 116(6):976-90. PubMed ID: 25767284
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of renal sympathetic denervation on glucose metabolism in patients with resistant hypertension: a pilot study.
    Mahfoud F; Schlaich M; Kindermann I; Ukena C; Cremers B; Brandt MC; Hoppe UC; Vonend O; Rump LC; Sobotka PA; Krum H; Esler M; Böhm M
    Circulation; 2011 May; 123(18):1940-6. PubMed ID: 21518978
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Catheter-based renal sympathetic denervation is effective in reducing office and ambulatory blood pressure in patients with resistant hypertension.
    Liu M; Chen J; Liu C; Huang D; Ke J; Tang W; Huang S; Wu W
    Int J Cardiol; 2014 Mar; 172(1):259-60. PubMed ID: 24462146
    [No Abstract]   [Full Text] [Related]  

  • 15. Renal denervation for hypertension: observations and predictions of a founder.
    Esler M
    Eur Heart J; 2014 May; 35(18):1178-85. PubMed ID: 24598982
    [TBL] [Abstract][Full Text] [Related]  

  • 16. What we need to know about renal nerve ablation for treatment of hypertension and other states of sympathetic overactivity.
    Schlaich MP
    Am J Physiol Renal Physiol; 2016 Dec; 311(6):F1267-F1270. PubMed ID: 27630063
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Renal denervation: what next?
    Joyner MJ
    Hypertension; 2014 Jul; 64(1):19-20. PubMed ID: 24732888
    [No Abstract]   [Full Text] [Related]  

  • 18. Is there a role for renal sympathetic denervation in the future treatment of resistant hypertension?
    Mahfoud F; Lenski M; Böhm M
    Future Cardiol; 2011 Sep; 7(5):591-4. PubMed ID: 21929337
    [No Abstract]   [Full Text] [Related]  

  • 19. Renal Sympathetic Denervation: Hibernation or Resurrection?
    Papademetriou V; Doumas M; Tsioufis C
    Cardiology; 2016; 135(2):87-97. PubMed ID: 27287994
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Transcatheter renal sympathetic denervation despite angiographically significant proximal stenosis: proof of concept from a case report.
    Giordano A; Polimeno M; Messina S; Corcione N; Ferraro P; Marullo L; Biondi-Zoccai G; Giordano G
    Int J Cardiol; 2014 Mar; 172(1):224-5. PubMed ID: 24439866
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.